ANTIVAX+ SAMPLE REPORT
Evidence Report 001

Vaccines and autism: how strong is the evidence?

A sample of the deeper ANTIVAX+ format: the claim, strongest evidence, methodological issues, source trail and conclusion in one research-oriented report.

Reviewed: 22 August 2026

Bottom line: Current high-quality evidence does not support a causal link between vaccines and autism. WHO's 2025 review assessed 31 primary studies from 2010–2025 plus five meta-analyses; the most rigorous studies and all five meta-analyses did not support an association. The NHS likewise states that research shows no link between MMR and autism.

1. The claim

The modern controversy became prominent after a 1998 paper suggested an association between MMR vaccination and autism. The paper was later retracted. The scientific question, however, did not end with that paper: researchers subsequently examined MMR, vaccines generally, thiomersal and aluminium-containing vaccines using much larger datasets and multiple study designs.

2. What the latest WHO review examined

WHO's Global Advisory Committee on Vaccine Safety reviewed literature published from 2010 to August 2025. Its systematic review included 31 primary research studies: 16 examining thiomersal-containing vaccines and autism spectrum disorder, and 15 examining vaccines and autism more broadly. It also considered five meta-analyses that included earlier research.

WHO reports that 20 of the 31 primary papers — including the most methodologically rigorous studies — and all five meta-analyses found no evidence supporting an association between vaccination and autism. WHO gave little evidential weight to studies it judged at critical risk of bias.

3. Aluminium and thiomersal

The 2025 WHO analysis also revisited concerns about aluminium adjuvants. It highlighted a large Danish nationwide cohort that found no association between early-childhood exposure to aluminium-adsorbed vaccines and 50 chronic disorders, including autism and other neurodevelopmental disorders. WHO also continues to state that thiomersal in vaccines has not been shown to cause autism or other neurodevelopmental disorders.

4. Why study quality matters

A statistical association is not automatically evidence of causation. Study design, confounding, selection bias, outcome definition and exposure measurement can all affect a result. WHO's committee explicitly gives greater weight to well-designed studies with low risk of bias and less weight to methodologically weak evidence.

5. Independent UK position

The NHS states that research has shown no link between MMR vaccination and autism. In August 2026, the MHRA also reaffirmed that multiple large, well-conducted studies involving millions of children have found no evidence that vaccines cause autism and noted that vaccine safety remains under continuous surveillance.

6. Conclusion

The evidence base is not a single study or authority statement. It consists of multiple large studies, systematic reviews, meta-analyses and ongoing pharmacovigilance. Taken together, the high-quality evidence does not support vaccines as a cause of autism.

Source trail

WHO — 2025 expert-group analysis
Summary of the updated GACVS review and conclusions.
WHO — Vaccines, Thimerosal and Autism Spectrum Disorder: evidence review 2010–2025
Technical evidence-review publication.
NHS — MMR vaccine
UK patient guidance including current autism statement and effectiveness information.
MHRA — Childhood vaccination safety, 12 August 2026
Current UK regulator statement and description of ongoing safety surveillance.

Open the companion Source Pack →